Seattle, Washington Sep 5, 2019 (Issuewire.com) - Global Bioactive Peptide Market, by Source (Plant, Milk, Eggs, Meat, Fish and Others), by Therapeutic Area (Antihypertensive, Antioxidant, Immunostimulatory, Antimicrobial, Diabetes, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others ), by Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa), was valued at US$ 3,265.2 million in 2017, and is projected to exhibit a CAGR of 9.4% over the forecast period (2018–2026), as highlighted in a new report published by Coherent Market Insights.
Companies operating in the global bioactive peptide market include Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., and Valio Oy among others.
Get The Holistic SAMPLE With Research Methodology: https://www.coherentmarketinsights.com/insight/request-sample/3018
Bioactive peptides are incorporated in dietary supplements, pharmaceuticals, and novel food supplements. Such formulations tailored with health benefits are used extensively across the globe to optimize health outcomes.
Collagen peptides are now being incorporated into a variety of sports and active nutrition products to improve the physical performance of athletes. In March 2019, Gelita launched the collagen peptide which can be used in a variety of functional and nutritional beverages. Moreover, collagen peptide is easily absorbed by body and is highly bioavailable.
According to a research report by the Massachusetts Institute of Technology (MIT), U.S. published in Feb 2017, researchers have designed a machine that can rapidly produce large quantities of customized peptides. The new tabletop machine can form links between amino acids in about 37 seconds, and it takes less than an hour to generate complete peptide molecules containing up to 60 amino acids.
Rising demand for cost effective, fast relief, and products beneficial for health is driving research and development activities. According to a study published in July 2017 in the Nature research Journal, scientists have developed a synthetic peptide that can specifically inhibit Zika virus infection. The researchers have synthesized a peptide (Z2) derived from the envelope protein that exhibits inhibitory effects on Zika virus infection.
Browse 36 Market Data Tables and 30 Figures spread through 167 Pages and in-depth TOC on “Bioactive Peptide Market”- Global Forecast to 2026, by Source (Plant, Milk, Eggs, Meat, Fish, and Others), by Therapeutic Area (Antihypertensive, Antioxidant, Immunostimulatory, Antimicrobial, Diabetes, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), by Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa),
To know the latest trends and insights prevalent in the global bioactive peptide market, click the link below:
https://www.coherentmarketinsights.com/market-insight/bioactive-peptide-market-3018
Market players are focused on the development of novel products, through partnerships and agreements. For instance, in July 2019, Nuritas and Stonehaven Incubate entered a partnership agreement for the development of advanced animal health solutions, with an initial focus on animal feed ingredient. Nuritas Ltd. combines artificial intelligence and genomics to discover and unlock natural Bioactive Peptides with extraordinary health benefits.
Key Takeaways of the Global Bioactive peptide Market:
The global bioactive peptide market is expected to exhibit a CAGR of 9.4% over the forecast period owing to increasing awareness and reliability on bioactive products is offering a strong consumer base for the market. Bioactive ingredients are essential for various health purposes, and to prevent chronic diseases that may occur due to lack of required nutrients in the body.
Among source, the plant-based bioactive peptide segment held the higher market share in 2018, owing to rising demand for effective as well as quality products, combined with technological advancements.
Among the therapeutic area, the antihypertensive segment held the higher market share in 2018 owing to rising prevalence of cardiovascular diseases such as coronary artery disease, congenital heart failure, and angina
Buy This Complete A Business Report: https://www.coherentmarketinsights.com/insight/buy-now/3018
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Media Contact
Coherent Market Insights sales@coherentmarketinsights.com 2067016702 Mr. Shah https://www.coherentmarketinsights.com
